Literature DB >> 19376744

Vestibular evoked myogenic potentials in response to lateral skull taps are dependent on two different mechanisms.

Krister Brantberg1, Magnus Westin, Lennart Löfqvist, Luca Verrecchia, Arne Tribukait.   

Abstract

OBJECTIVE: To explore the mechanisms for skull tap induced vestibular evoked myogenic potentials (VEMP).
METHODS: The muscular responses were recorded over both sternocleidomastoid (SCM) muscles using skin electrodes. A skull tapper which provided a constant stimulus intensity was used to test cervical vestibular evoked myogenic potentials (VEMP) in response to lateral skull taps in healthy subjects (n=10) and in patients with severe unilateral loss of vestibular function (n=10).
RESULTS: Skull taps applied approximately 2 cm above the outer ear canal caused highly reproducible VEMP. There were differences in VEMP in both normals and patients depending on side of tapping. In normals, there was a positive-negative ("normal") VEMP on the side contra-lateral to the skull tapping, but no significant VEMP ipsi-laterally. In patients, skull taps above the lesioned ear caused a contra-lateral positive-negative VEMP (as it did in the normals), in addition there was an ipsi-lateral negative-positive ("inverted") VEMP. When skull taps were presented above the healthy ear there was only a small contra-lateral positive-negative VEMP but, similar to the normals, no VEMP ipsi-laterally.
CONCLUSIONS: The present data, in conjunction with earlier findings, support a theory that skull-tap VEMP responses are mediated by two different mechanisms. It is suggested that skull tapping causes both a purely ipsi-lateral stimulus side independent SCM response and a bilateral and of opposite polarity SCM response that is stimulus side dependent. Possibly, the skull tap induced VEMP responses are the sum of a stimulation of two species of vestibular receptors, one excited by vibration (which is rather stimulus site independent) and one excited by translation (which is more stimulus site dependent). SIGNIFICANCE: Skull-tap VEMP probably have two different mechanisms. Separation of the two components might reveal the status of different labyrinthine functions.

Entities:  

Mesh:

Year:  2009        PMID: 19376744     DOI: 10.1016/j.clinph.2009.03.008

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  [Recording cervical and ocular vestibular evoked myogenic potentials: part 1: anatomy, physiology, methods and normal findings].

Authors:  L E Walther; K Hörmann; O Pfaar
Journal:  HNO       Date:  2010-10       Impact factor: 1.284

2.  Clinical testing of otolith function: perceptual thresholds and myogenic potentials.

Authors:  Yuri Agrawal; Tatiana Bremova; Olympia Kremmyda; Michael Strupp; Paul R MacNeilage
Journal:  J Assoc Res Otolaryngol       Date:  2013-12

3.  Brain and Behavioral Evidence for Reweighting of Vestibular Inputs with Long-Duration Spaceflight.

Authors:  K E Hupfeld; H R McGregor; V Koppelmans; N E Beltran; I S Kofman; Y E De Dios; R F Riascos; P A Reuter-Lorenz; S J Wood; J J Bloomberg; A P Mulavara; R D Seidler
Journal:  Cereb Cortex       Date:  2022-02-08       Impact factor: 4.861

4.  Direction-dependent excitatory and inhibitory ocular vestibular-evoked myogenic potentials (oVEMP) produced by oppositely directed accelerations along the midsagittal axis of the head [corrected].

Authors:  Peter Jombik; Pavel Spodniak; Vladimír Bahyl
Journal:  Exp Brain Res       Date:  2011-04-22       Impact factor: 1.972

5.  Functional Brain Activation in Response to a Clinical Vestibular Test Correlates with Balance.

Authors:  Fatemeh Noohi; Catherine Kinnaird; Yiri DeDios; Igor S Kofman; Scott Wood; Jacob Bloomberg; Ajitkumar Mulavara; Rachael Seidler
Journal:  Front Syst Neurosci       Date:  2017-03-10

6.  Clinical use of skull tap vestibular evoked myogenic potentials for the diagnoses of the cerebellopontine angle tumor patients.

Authors:  Erdem Yavuz; Magdalena Lachowska; Katarzyna Pierchała; Krzysztof Morawski; Kazimierz Niemczyk; Rafael E Delgado
Journal:  Biomed Res Int       Date:  2014-04-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.